. 2018 Apr;6(8):151. doi: 10.21037/atm.2018.04.06

Table 2. Specific discrepancy between Phadiatop and previous ImmunoCAP findings in small subsets of asthmatics and non-asthmatic controls.

Subset	Subject ID#	hx2 (kU_A/L)	mx2 (kU_A/L)	tx4 (kU_A/L)	wx5 (kU_A/L)	Phadiatop (kU_A/L)
Subset A	E3001006	4.66	0.31	0.86	0.70	30.93
	E1005006	0.98	0.06	0.08	0.04	13.21
	E1007002	0.70	0.13	0.06	0.04	6.82
	E1005017	0.02	0.03	0.87	0.25	5.34
	E3006019	0.61	0.06	0.08	0.26	6.24
Subset B	E1009009	0.12	0.36	0.13	0.07	0.33
	E1006004	0.11	0.41	0.10	0.07	0.30
	E3001018	0.07	0.43	0.07	0.04	0.29
	E2001005	0.05	0.48	0.04	0.04	0.22
	E2008005	0.03	0.37	0.06	0.02	0.12
	E2004002	0.02	0.76	0.08	0.03	0.09
	E3006020	0.01	0.90	0.04	0.03	0.07
	E1004039	0.03	0.38	0.08	0.03	0.07
Subset C	E1004001	0.02	0.11	0.04	0.04	1.86
	E1004004	0.29	0.07	0.05	0.06	4.76
	E1009002	0.15	0.11	0.10	0.07	0.39
	E2007009	0.23	0.06	0.06	0.04	0.35
	E3002019	0.09	0.06	0.09	0.04	0.37
	E3004012	0.17	0.06	0.04	0.08	0.4
	E3006013	0.19	0.06	0.05	0.02	0.37

Subset A: five serum samples from the asthma group, showing high values of total Phadiatop sIgE levels but meanwhile 5 to 10 times lower levels of allergen mix sIgE although they were both positive by Phadiatop and previous ImmunoCAP assays; Subset B: eight serum samples from the asthma group, mono-positive to mx2 but negative by Phadiatop, with mx2 sIgE levels between 0.35 and 0.90 kU_A/L, and total Phadiatop sIgE level largely between 0.10 and 0.35 kU_A/L; Subset C: seven serum samples from the non-asthma group were Phadiatop-positive but tested negative for allergen mix. hx2, house dust mix; mx2, molds and yeasts mix; tx4, tree pollen mix; wx5, weed mix.